Get started
Author

Fabian Schnitzler

Observed names: F Schnitzler, F. Schnitzler, Schnitzler, F., Schnitzler, Fabian
Observed institutions: Brigham and Women's Hospital, Harvard University, Universitair Ziekenhuis Leuven, LMU Klinikum, Helios Amper-Klinikum Dachau, Lungenheilkunde München-Pasing, Agaplesion Markus Hospital, Ludwig-Maximilians-Universität München
ORCID: 0000-0001-8260-8594
Observed ORCID: 0000-0001-8260-8594
OpenAlex ID: A5037150306
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease
2009 · Fabian Schnitzler, Herma Fidder, et al. · Inflammatory Bowel Diseases · 680
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
2008 · F Schnitzler, H Fidder, et al. · Gut · 532
PDF
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
2008 · H Fidder, F Schnitzler, et al. · Gut · 449
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis
2009 · I Arijs, K Li, et al. · Gut · 422
PDF
Long-term outcome after infliximab for refractory ulcerative colitis
2008 · Marc Ferrante, Séverine Vermeire, et al. · Journal of Crohn s and Colitis · 223
Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy
2011 · Fabian Schnitzler, Herma Fidder, et al. · Inflammatory Bowel Diseases · 195
PDF
Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease
2011 · Matthias Jürgens, Jestinah M. Mahachie John, et al. · Clinical Gastroenterology and Hepatology · 193
Predictors of early response to infliximab in patients with ulcerative colitis
2006 · Marc Ferrante, Séverine Vermeire, et al. · Inflammatory Bowel Diseases · 193
Disease Activity, ANCA, and IL23R Genotype Status Determine Early Response to Infliximab in Patients With Ulcerative Colitis
2010 · Matthias Jürgens, Rüdiger P Laubender, et al. · The American Journal of Gastroenterology · 169
Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn’s disease
2005 · H-P Török, J Glas, et al. · Gut · 158
PDF
Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status
2015 · Johannes Stallhofer, Matthias Friedrich, et al. · Inflammatory Bowel Diseases · 136
Increased Expression of the Chemokine Fractalkine in Crohn's Disease and Association of the Fractalkine Receptor T280M Polymorphism with a Fibrostenosing Disease Phenotype
2005 · Stephan Brand, Katrin Hofbauer, et al. · The American Journal of Gastroenterology · 103
Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohnʼs disease in clinical practice: Results of a Prospective Study
2006 · Julia Seiderer, Stephan Brand, et al. · Inflammatory Bowel Diseases · 98
Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-α antibody-treated patients with inflammatory bowel disease
2010 · Florian Beigel, Fabian Schnitzler, et al. · Inflammatory Bowel Diseases · 87
Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti‐TNF alpha antibodies
2014 · Florian Beigel, Anni Steinborn, et al. · Pharmacoepidemiology and Drug Safety · 80
Homozygosity for theCARD15frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis
2006 · Julia Seiderer, Fabian Schnitzler, et al. · Scandinavian Journal of Gastroenterology · 78
Clinical outcomes with ustekinumab as rescue treatment in therapy‐refractory or therapy‐intolerant ulcerative colitis
2019 · Thomas Ochsenkühn, Cornelia Tillack, et al. · United European Gastroenterology Journal · 60
PDF
The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn’s disease independent of the IL23R genotype
2010 · Matthias Jürgens, Stephan Brand, et al. · Journal of Gastroenterology · 54
Macrophage migration inhibitory factor (MIF) −173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohnʼs disease
2006 · Julia Dambacher, Tanja Staudinger, et al. · Inflammatory Bowel Diseases · 50
Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort
2015 · Fabian Schnitzler, Matthias Friedrich, et al. · PLoS ONE · 43
PDF
Role of the NFKB1 −94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes
2006 · Jürgen Glas, Helga-Paula Török, et al. · Inflammatory Bowel Diseases · 43
Eight novel CARD15 variants detected by DNA sequence analysis of the CARD15 gene in 111 patients with inflammatory bowel disease
2006 · Fabian Schnitzler, Stephan Brand, et al. · Immunogenetics · 43
The NOD2 Single Nucleotide Polymorphism rs72796353 (IVS4+10 A>C) Is a Predictor for Perianal Fistulas in Patients with Crohn's Disease in the Absence of Other NOD2 Mutations
2015 · Fabian Schnitzler, Matthias Friedrich, et al. · PLoS ONE · 34
PDF
Rate and Predictors of Mucosal Healing in Patients with Inflammatory Bowel Disease Treated with Anti-TNF-Alpha Antibodies
2014 · Florian Beigel, Matthias Deml, et al. · PLoS ONE · 31
PDF
The NOD2 p.Leu1007fsX1008 Mutation (rs2066847) Is a Stronger Predictor of the Clinical Course of Crohn's Disease than the FOXO3A Intron Variant rs12212067
2014 · Fabian Schnitzler, Matthias Friedrich, et al. · PLoS ONE · 29
PDF
Works count: 89
Citation count: 4,384
H-index: 26
I10-index: 32
Year
Topic
Type